ACE2 and infection: We found that ACE2 binding inhibition was significantly higher among previously infected individuals than infection-naive individuals after a single vaccine dose (94.3% versus 37.3%, P < 0.001), with no between-group difference seen after the second dose (100.0% versus 97.8%, P = 1.00).